The injectable form is marketed as Ozempic (approved for diabetes) and Wegovy (approved for weight management), while the oral version is sold as Rybelsus (approved for diabetes)
The best path forward with semaglutide is to work with a knowledgeable healthcare provider who can help you find the right dosage where you can see results but also minimize side effects
Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is an injectable prescription medicine used: along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes and known heart disease to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease It is not known if Ozempic is safe and effective for use in children
Factors such as medication dose, adherence, initial weight, and presence of diabetes can all influence your outcome
Trial data show patients regain about two-thirds of lost weight within one year of stopping semaglutide